R&D spending by Canada’s pharmaceutical industry declined in 2003 after 14 consecutive years of increases and dipped below the critical 10% R&D-to-sales ratio. The 2003 ratio for all patentees is 8.
... Please become a Member or login to read the rest of this article ...
Other stories mentioning these organizations, people and topics
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively
in accordance with our Privacy Policy and Terms of Service.